Sascha G. Wolf, Conclusion in:
Pharmaceutical Expenditure in Germany , page 66 - 66
Future Development, Political Influence and Economic Impact
Available
- doi.org/10.5771/9783845220055
- ISBN print: 978-3-8329-4164-2
- ISBN online: 978-3-8452-2005-5
- Nomos, Baden-Baden
Chapter Preview
- page 2–6 Titelei/Inhaltsverzeichnis
- page 7–8 Acknowledgments
- page 9–10 Zusammenfassung / Abstract
- page 11–12 Contents
- page 13–14 List of Abbreviations
- page 15–161. Introduction
- page 17–442. The Future Development of Pharmaceutical Expenditure in Germany
- page 17–182.1. Introduction
- page 18–212.2. Forecasting Health Care Expenditure – Review of the Literature
- page 21–252.3. Age and Health Care Expenditure
- page 25–372.4. Medicalisation and Compression Theses in the Pharmaceutical Sector
- page 37–422.5. Forecasting Pharmaceutical Expenditure
- page 42–442.6. Political Implications
- page 44–442.7. Conclusion
- page 45–663. Health Politics under Suspicion – a Public Choice Perspective
- page 45–463.1. Introduction
- page 46–483.2. Development of Drug Expenditure
- page 48–493.3. Common Explanation Approach
- page 49–503.4. The Perspective of Public Choice
- page 50–643.5. Model Specification and Methodology
- page 64–663.6. Empirical Observations
- page 66–663.7. Conclusion
- page 67–894. Reference Pricing versus Medical Savings Accounts
- page 67–684.1. Introduction
- page 68–704.2. Generic Competition
- page 70–734.3. Reference Pricing as an Insufficient Surrogate for Market Competition
- page 73–764.4. More Competition via Medical Savings Accounts
- page 76–824.5. Economic Analysis I: Price Equilibrium
- page 82–874.6. Economic Analysis II: Quality Equilibrium
- page 87–894.7. Financing Pharmaceutical Expenditure by means of Medical Savings Accounts
- page 89–894.8. Conclusion
- page 90–925. Conclusion
- page 93–98 Appendix
- page 99–108 Bibliography